Loading...
Header Logo
Keywords
Last Name
Institution

MICHAEL R MIGDEN

TitleAssociate Professor
InstitutionMD Anderson
DepartmentDermatology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Migden MR, Chandra S, Rabinowits G, Chen CI, Desai J, Seluzhytsky A, Sasane M, Campanelli B, Chen Z, Freeman ML, Ibrahim SF, Khushalani NI, Andria M, Ruiz E. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Future Oncol. 2020 Feb; 16(4):11-19. PMID: 31951149.
      View in: PubMed
    2. Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, Schadendorf D, Guminski A, Hauschild A, Wong DJ, Daniels GA, Berking C, Jankovic V, Stankevich E, Booth J, Li S, Weinreich DM, Yancopoulos GD, Lowy I, Fury MG, Rischin D. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020 Feb; 21(2):294-305. PMID: 31952975.
      View in: PubMed
    3. Tam S, Yao CMK, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2019 Dec 05. PMID: 31804658.
      View in: PubMed
    4. Aria AB, Rosenbaum LE, Migden MR. Multiple inguinal basal cell carcinomas in the setting of intertrigo. Indian J Dermatol Venereol Leprol. 2019 Nov 08. PMID: 31710000.
      View in: PubMed
    5. Ahmed SR, Petersen E, Patel R, Migden MR. Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma. Expert Rev Clin Pharmacol. 2019 Oct; 12(10):947-951. PMID: 31524530.
      View in: PubMed
    6. Phadnis SS, Chen L, Wang WL, Migden MR, Zaky W. Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy. Pediatr Blood Cancer. 2019 12; 66(12):e27974. PMID: 31502413.
      View in: PubMed
    7. Silapunt S, Agwu AV, Migden MR. Severe pretibial myxedema refractory to systemic immunosuppressants. Cutis. 2019 Sep; 104(3):E1-E3. PMID: 31675401.
      View in: PubMed
    8. Petersen ET, Ahmed SR, Chen L, Silapunt S, Migden MR. Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma. Future Oncol. 2019 Sep; 15(27):3171-3184. PMID: 31382778.
      View in: PubMed
    9. Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A. Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2019 04 18; 19(1):366. PMID: 30999949.
      View in: PubMed
    10. Sundaresan S, Migden MR, Silapunt S. Treatment of Leg Veins for Restless Leg Syndrome: A Retrospective Review. Cureus. 2019 Apr 02; 11(4):e4368. PMID: 31192073.
      View in: PubMed
    11. Chen L, Aria AB, Silapunt S, Migden MR. Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer. Dermatol Surg. 2019 01; 45(1):1-16. PMID: 30045105.
      View in: PubMed
    12. Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P. Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread. J Cutan Pathol. 2019 Feb; 46(2):152-158. PMID: 30414196.
      View in: PubMed
    13. Aria A, Chen L, Rosenbaum LE, Migden MR. Mohs Micrographic Surgery for the Treatment of Cutaneous Metastases in a Patient With Papillary Thyroid Carcinoma. Dermatol Surg. 2018 11; 44(11):1457-1459. PMID: 29293107.
      View in: PubMed
    14. Yao C, Swaby MG, Migden MR, Silapunt S. A Nodular Hidradenoma of Atypical Location in Pregnancy. Acta Derm Venereol. 2018 Oct 10; 98(9):908-909. PMID: 29856466.
      View in: PubMed
    15. Rosenbaum LE, Migden MR. A Tender Subcutaneous Fluctuant Forehead Nodule: An Unexpected Foray Into the Cranium. Dermatol Surg. 2018 Sep; 44(9):1224-1227. PMID: 29315144.
      View in: PubMed
    16. Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, Rabinowits G, Thai AA, Dunn LA, Hughes BGM, Khushalani NI, Modi B, Schadendorf D, Gao B, Seebach F, Li S, Li J, Mathias M, Booth J, Mohan K, Stankevich E, Babiker HM, Brana I, Gil-Martin M, Homsi J, Johnson ML, Moreno V, Niu J, Owonikoko TK, Papadopoulos KP, Yancopoulos GD, Lowy I, Fury MG. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2018 07 26; 379(4):341-351. PMID: 29863979.
      View in: PubMed
    17. Balasubramanyam S, Migden MR, Silapunt S. Venous Treatment of Lipodermatosclerosis to Improve Ambulatory Function. Dermatol Surg. 2018 May; 44(5):749-752. PMID: 28858931.
      View in: PubMed
    18. Chen L, Parsons AM, Aria AB, Ciurea AM, Patel AB, Chan C, Griffin JR, Nguyen TH, Migden MR. Surgical site identification with personal digital device: A prospective pilot study. J Am Acad Dermatol. 2018 Sep; 79(3):520-524. PMID: 29524583.
      View in: PubMed
    19. Freemyer BD, Migden MR, Silapunt S. Linear terra firma-forme dermatosis of the midline back. Cutis. 2018 Mar; 101(3):205-206. PMID: 29718014.
      View in: PubMed
    20. Bendell J, Andre V, Ho A, Kudchadkar R, Migden M, Infante J, Tiu RV, Pitou C, Tucker T, Brail L, Von Hoff D. Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma. Clin Cancer Res. 2018 05 01; 24(9):2082-2091. PMID: 29483143.
      View in: PubMed
    21. Li JY, Silapunt S, Migden MR, McGinness JL, Nguyen TH. Mohs Mapping Fidelity: Optimizing Orientation, Accuracy, and Tissue Identification in Mohs Surgery. Dermatol Surg. 2018 Jan; 44(1):1-9. PMID: 28654580.
      View in: PubMed
    22. English CA, Chen L, Migden MR. Traction haemostasis. Australas J Dermatol. 2018 May; 59(2):156-157. PMID: 29243226.
      View in: PubMed
    23. Migden MR, Chang ALS, Dirix L, Stratigos AJ, Lear JT. Emerging trends in the treatment of advanced basal cell carcinoma. Cancer Treat Rev. 2018 Mar; 64:1-10. PMID: 29407368.
      View in: PubMed
    24. Chen L, Aria AB, Silapunt S, Lee HH, Migden MR. Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial. Future Oncol. 2018 Mar; 14(6):515-525. PMID: 29119833.
      View in: PubMed
    25. Rosales Santillan M, ATajnert K, Swaby MG, Migden MR, Silapunt S. Multiple eccrine spiradenomas in a zosteriform pattern. Dermatol Online J. 2017 Aug 15; 23(8). PMID: 29469747.
      View in: PubMed
    26. Sundaresan S, Migden MR, Silapunt S. Stasis Dermatitis: Pathophysiology, Evaluation, and Management. Am J Clin Dermatol. 2017 Jun; 18(3):383-390. PMID: 28063094.
      View in: PubMed
    27. Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017 05 16; 17(1):332. PMID: 28511673.
      View in: PubMed
    28. Migden M, Xie J, Wei J, Tang W, Herrera V, Palmer JB. Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014. J Am Acad Dermatol. 2017 Jul; 77(1):55-62.e3. PMID: 28392293.
      View in: PubMed
    29. Wu W, Chavez-Frazier A, Migden M, Nguyen T. The Buried Half Horizontal, Half Vertical Mattress Suture: A Novel Technique for Wound Edges of Unequal Lengths. Dermatol Surg. 2016 Dec; 42(12):1391-1393. PMID: 27427995.
      View in: PubMed
    30. Chang AL, Lewis KD, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A. Safety and efficacy of vismodegib in patients aged =65 years with advanced basal cell carcinoma. Oncotarget. 2016 11 15; 7(46):76118-76124. PMID: 27764798.
      View in: PubMed
    31. Migden M. Hedgehog pathway inhibitor therapy in basal-cell nevus syndrome. Lancet Oncol. 2016 12; 17(12):1631-1632. PMID: 27838223.
      View in: PubMed
    32. Doan HQ, Silapunt S, Migden MR. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. Onco Targets Ther. 2016; 9:5671-5678. PMID: 27695345.
      View in: PubMed
    33. Chang AL, Arron ST, Migden MR, Solomon JA, Yoo S, Day BM, McKenna EF, Sekulic A. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials. Orphanet J Rare Dis. 2016 09 01; 11(1):120. PMID: 27581207.
      View in: PubMed
    34. Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, Shen J, Takata Y, McNiece K, Polansky MA, Abbas HA, Rajapakshe K, Gower A, Spira A, Covington KR, Xiao W, Gunaratne P, Pickering C, Frederick M, Myers JN, Shen L, Yao H, Su X, Rapini RP, Wheeler DA, Hawk ET, Flores ER, Tsai KY. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nat Commun. 2016 08 30; 7:12601. PMID: 27574101.
      View in: PubMed
    35. Silapunt S, Chen L, Migden MR. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness. Ther Adv Med Oncol. 2016 Sep; 8(5):375-82. PMID: 27583029.
      View in: PubMed
    36. Chen L, Silapunt S, Migden MR. Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update. Future Oncol. 2016 Sep; 12(18):2095-105. PMID: 27189494.
      View in: PubMed
    37. Dummer R, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Gogov S, Pallaud C, Yi T, Mone M, Chang AL, Cornélis F, Kudchadkar R, Trefzer U, Lear JT, Sellami D, Migden MR. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. J Am Acad Dermatol. 2016 Jul; 75(1):113-125.e5. PMID: 27067394.
      View in: PubMed
    38. Sekulic A, Migden MR, Lewis K, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Dirix L, Hou J, Yue H, Hauschild A. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol. 2015 Jun; 72(6):1021-6.e8. PMID: 25981002.
      View in: PubMed
    39. Migden MR, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kudchadkar R, Trefzer U, Gogov S, Pallaud C, Yi T, Mone M, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Chang AL, Cornélis F, Lear JT, Sellami D, Dummer R. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015 Jun; 16(6):716-28. PMID: 25981810.
      View in: PubMed
    40. Ozgur OK, Yin V, Chou E, Ball S, Kies M, William WN, Migden M, Thuro BA, Esmaeli B. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome. Am J Ophthalmol. 2015 Aug; 160(2):220-227.e2. PMID: 25935097.
      View in: PubMed
    41. Sharpe HJ, Pau G, Dijkgraaf GJ, Basset-Seguin N, Modrusan Z, Januario T, Tsui V, Durham AB, Dlugosz AA, Haverty PM, Bourgon R, Tang JY, Sarin KY, Dirix L, Fisher DC, Rudin CM, Sofen H, Migden MR, Yauch RL, de Sauvage FJ. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 2015 Mar 09; 27(3):327-41. PMID: 25759019.
      View in: PubMed
    42. Lim L, Nichols B, Migden MR, Rajaram N, Reichenberg JS, Markey MK, Ross MI, Tunnell JW. Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis. J Biomed Opt. 2014; 19(11):117003. PMID: 25375350.
      View in: PubMed
    43. Anzalone CL, Cohen PR, Migden MR, Tannir NM. Mohs surgery in metastatic cancer: renal cell carcinoma solitary cutaneous metastasis and visceral tumor metastases to skin treated with microscopically controlled surgical excision. Int J Dermatol. 2013 Jul; 52(7):856-61. PMID: 23675612.
      View in: PubMed
    44. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012 Jun 07; 366(23):2171-9. PMID: 22670903.
      View in: PubMed
    45. Rajaram N, Reichenberg JS, Migden MR, Nguyen TH, Tunnell JW. Pilot clinical study for quantitative spectral diagnosis of non-melanoma skin cancer. Lasers Surg Med. 2010 Dec; 42(10):716-27. PMID: 21246575.
      View in: PubMed
    46. Migden M, Chavez-Frazier A, Nguyen T. The use of high definition video modules for delivery of informed consent and wound care education in the Mohs Surgery Unit. Semin Cutan Med Surg. 2008 Mar; 27(1):89-93. PMID: 18486030.
      View in: PubMed
    47. Cowl CT, Prakash UB, Shawn Mitchell P, Migden MR. Varicella-zoster virus detection by polymerase chain reaction using bronchoalveolar lavage specimens. Am J Respir Crit Care Med. 2000 Aug; 162(2 Pt 1):753-4. PMID: 10934116.
      View in: PubMed
    48. Migden MR, Dennis WH, Clinch TE. Testing for hepatitis B surface antigen in processing donor tissue for penetrating keratoplasty. Am J Ophthalmol. 1996 Sep; 122(3):439-42. PMID: 8794725.
      View in: PubMed
    49. Migden M, Elkins BS, Clinch TE. Phototherapeutic keratectomy for corneal scars. Ophthalmic Surg Lasers. 1996 May; 27(5 Suppl):S503-7. PMID: 8724160.
      View in: PubMed
    50. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome. Orphanet Journal of Rare Diseases. 11.
    51. The Buried Half Horizontal, Half Vertical Mattress Suture. Dermatologic Surgery. 42:1391-1393.
    52. In vivo determination of optical properties and fluorophore characteristics of non-melanoma skin cancer.
    53. Oncotarget. 7:76118-76124.
    54. Sonidegib for the treatment of advanced basal cell carcinoma. Future Oncology. 12:2095-2105.
    55. Reconstruction of the Ears. 135-145.
    56. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nature Communications. 7.
    57. Hedgehog pathway inhibitor therapy in basal-cell nevus syndrome. The Lancet Oncology. 17:1631-1632.
    58. Mohs' micrographic surgery of the periorbital area. 571-587.
    59. Hedgehog pathway inhibition in advanced basal cell carcinoma. Therapeutic Advances in Medical Oncology. 8:375-382.
    60. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT). Journal of the American Academy of Dermatology.
    61. Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma. OncoTargets and Therapy. 9:5671-5678.
    MIGDEN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description